Cargando…
Combined Treatment with Doxorubicin and Rapamycin Is Effective against In Vitro and In Vivo Models of Human Glioblastoma
Despite numerous clinical trials, glioblastoma (GBM) remains a tumor that is difficult to treat. The aim of this study was to investigate the potential of a new pharmacological approach, combining doxorubicin (Dox) and rapamycin (Rapa), in in vitro and in vivo GBM models. Cytotoxic and anti-prolifer...
Autores principales: | Iorio, Anna Lisa, Da Ros, Martina, Pisano, Claudio, de Martino, Maurizio, Genitori, Lorenzo, Sardi, Iacopo |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
MDPI
2019
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6462908/ https://www.ncbi.nlm.nih.gov/pubmed/30857276 http://dx.doi.org/10.3390/jcm8030331 |
Ejemplares similares
-
Aldoxorubicin and Temozolomide combination in a xenograft mice model of human glioblastoma
por: Da Ros, Martina, et al.
Publicado: (2018) -
Tumor response of temozolomide in combination with morphine in a xenograft model of human glioblastoma
por: Iorio, Anna Lisa, et al.
Publicado: (2017) -
Glioblastoma Chemoresistance: The Double Play by Microenvironment and Blood-Brain Barrier
por: Da Ros, Martina, et al.
Publicado: (2018) -
Blood-Brain Barrier and Breast Cancer Resistance Protein: A Limit to the Therapy of CNS Tumors and Neurodegenerative Diseases
por: Iorio, Anna Lisa, et al.
Publicado: (2016) -
A microRNA profile of pediatric glioblastoma: The role of NUCKS1 upregulation
por: Giunti, Laura, et al.
Publicado: (2019)